The Peptide Boom: What Consumers Need to Know
Compounded peptides are gaining attention, but questions about quality, safety and effectiveness remain. Here’s why evidence and clear standards matter.
regulation
Balancing AI risks and benefits
A balanced view of AI emphasizes realism: recognize risks, harness benefits, and push for thoughtful regulation and safeguards.
Regulation Tightens Around Homeopathic Products
Regulatory and legal pressure tightens around the U.S.A. homeopathic industry, fuelling debate over safety and legitimacy.
Democracy vs. data brokers’ billion-dollar game
A call to push for clear opt-in rules, transparency, and stronger penalties to curb data abuse in tech, cars, and other devices.
Hype, progress, and the AI regulatory dilemma
A concise look at the AI 2027 scenario, its plausibility, and why guardrails and international dialogue matter to steer innovation responsibly. #AI #ArtificialInteligence
Balancing Safety and Innovation
Gain-of-function research is often misunderstood, leading to fears that could harm scientific progress. Understanding its importance is key to fostering innovation while ensuring safety.